Medical Device | March 13, 2022
S.M.A.R.T. Radianz Vascular Stent System approved for transradial use in the U.S.
It signals Cordis' renewed investment in innovation
It signals Cordis' renewed investment in innovation
Paxlovid consists of nirmatrelvir, which inhibits a SARS-CoV-2 protein to stop the virus from replicating, and ritonavir, which slows down nirmatrelvir’s breakdown to help it remain in the body for a longer period at higher concentrations
Company expects strong organic growth in sales, EBITDA in 2022
N Yuvraj, Joint Secretary, Dept of Pharmaceuticals, Satish Reddy, Chairman, Dr Reddy’s Laboratories; Kiran Mazumdar Shaw, Executive Chairperson, Biocon Group; Sanjiv Navangul, MD & CEO, Bharat Serums and Vaccines and Shravil Patel, MD, Zydus Lifesciences discuss the way forward for the India pharma industry
The companies plan to use the proceeds to retire debt and expand operations
AptarGroup acquired Voluntis and 80% of Weihai Hengyu Medical Products in 2021.
It will open new frontier for south-to-south collaboration and innovation transfer
The acquisition would enable addition of established brands with high recall amongst healthcare professionals, especially in the vitamins, minerals and supplements category
Intuitive Telepresence (ITP), facilitates remote learning, and encourages interaction and collaboration between surgeons without the need to travel
Collaboration aims to develop innovative machine learning and artificial intelligence solutions for personalized and earlier treatment in neurology
Subscribe To Our Newsletter & Stay Updated
